GPT HEALTHCARE LTD Q3 RESULTS
GPT Infraprojects 1:1 bonus issue: Last day today to buy shares to qualify before record date
GPT Infraprojects amazes with soaring net profits and stake acquisition, reflecting a prosperous future ahead.
Q4 results: Stable costs boost India Inc. profits
Steady costs and firm domestic demand supported corporate performance in the March quarter.
Apollo Hospitals shares rally 3% after reporting Rs 258 crore profit. Should you buy, sell or hold?
Apollo Hospitals Share Price: Apollo Hospitals shares surged by 3.4% during Friday's early trading session, reaching a peak of Rs 5,955. This uptick followed the company's announcement of a significant 77% year-on-year (YoY) increase in its net profit.
Apollo Hospitals Q4 Results: Net profit rises 76% YoY to Rs 254 crore
Revenue grew 15% YoY to Rs.4,944 crore in Q4FY24. The earnings before interest, tax, depreciation and ammortisation (EBITDA), EBITDA rose 31% YoY to Rs.640 crore in Q4FY24. The EBITDA margins expanded 161 basis points YoY to 12.95%.
3M India Q4 Results: 'Post-it' maker posts profit rise; shares surge
3M INDIA-RESULTS/'Post-it' maker 3M India posts Q4 profit rise; shares surge
IRCTC, ABFRL, JSW Holdings among 453 companies declaring Q4 results on Tuesday
453 companies, including IRCTC and Aditya Birla Fashion, are set to declare Q4 results. Most companies report profits, boosting Nifty and Sensex to new highs. Market bullish ahead of Lok Sabha elections.
Fortis Healthcare Q4 Results: Net profit jumps 47% YoY to Rs 203 crore
Fortis Healthcare Ltd on Thursday reported a 46.88 per cent increase in consolidated net profit at Rs 203.14 crore in the fourth quarter ended March 2024 on the back of higher revenue from its core business.
Q4 results today: ITC, IndiGo among 181 companies to announce earnings on Thursday
181 companies, including IndiGo and ITC, will announce their quarterly earnings for Jan-Mar 2024. IndiGo is expected to post healthy earnings, while ITC may see muted revenue growth.
Max Healthcare Institute Q4 Results: PAT down 3% YoY to Rs 311 crore
Max Healthcare Institute Ltd on Wednesday reported a 2.81 per cent decline in profit after tax at Rs 311 crore in the fourth quarter ended March 31, 2024. The company had posted a Profit After Tax (PAT) of Rs 320 crore in the same quarter of the previous fiscal, Max Healthcare Institute said in a statement.
Max Healthcare Q4 Results: Net profit drops 3% YoY to Rs 311 crore
Max Healthcare's Q4FY24 net profit dips 3% YoY to Rs 311 crore, attributed to lower effective tax rate in Q4FY23 and new unit losses. Gross revenue rises 15% YoY to Rs 1,890 crore.
Global Health Q4 Results: Net profit rises 25% to Rs 127 crore
For the year ended on March 31, 2024, the company said its net profit increased to Rs 478 crore as against Rs 326 crore in FY23.
Mankind Pharma Q4 Results: Net profit jumps 62% YoY to Rs 477 crore
Mankind Pharma on Wednesday reported 62% year-on-year (YoY) jump in net profit to Rs 477 crore in Q4FY24 led by strong domestic formulation sales and one-off US export opportunities.
Do Dr Lal Pathlabs' results indicate a turnaround for the sector? 4 stocks from diagnostic space, 3 with upside potential of up to 31%
Some sectors have a company which can be called as the bell weather of that sector and that is why its results of that company probably are indicative of what is happening in the sector. In case of the diagnostic, it is probably the Dr Lals path labs which would fit the criteria, it has national presence, large network, present in both physical and digital segment. So when the quarterly numbers come and they show improvement on many fronts then probably it is time to have a look at them more seriously and see if there is a possible turnaround building in the sector. This became even more important because these stocks had gained extremely high valuation and also popularity in terms of both retail and institutional participation. But then for close to two years, they have been a strong under performer in a strong bull market. Does this result mean that finally in terms of price war for customer acquisition over and now the valuation readjustment will start in the upward direction.
Aster DM Healthcare Q3 Results: Net profit rises 29% at Rs 179 crore
Aster DM Healthcare on Friday said its consolidated net profit increased 29 per cent to Rs 179 crore in the third quarter ended December 2023. The healthcare provider had reported a net profit of Rs 139 crore in the year-ago period.
Fortis Healthcare Q3 Results: Net profit drops 11% YoY to Rs 134 crore
The operating earnings before interest, tax, depreciation and amortisation (EBITDA) rose 6.8% YoY to Rs 284 crore. The EBITDA margins declined 80 basis points to 16.9%.
Metropolis Healthcare Q3 Results: Net profit drops 25% to Rs 27 crore
"The performance in Q3 was marginally impacted on account of heavy rainfall and floods in Chennai and adjacent areas in December 2023, leading to loss of revenues for approx. 7-8 days from Chennai region, which is one of the focus cities for Metropolis," Ameera Shah, promoter and managing director of Metropolis Healthcare said.
Q3 results today: Tata Motors, Delhivery, Indigo among 130 companies to announce earnings
Nearly 130 companies, including Tata Motors and Indigo, will be announcing their December quarter earnings. Tata Motors is expected to have a strong performance due to robust demand for vehicles in India and growth in volumes for Jaguar Land Rover. Indigo is also expected to post strong profit growth driven by improving passenger yields and fare prices.
Max Healthcare Q3 Results: Net profit zooms 26% YoY to Rs 338 crore
Gross revenue rose 14% to Rs 1779 crore during Q3FY24 compared to Rs 1559 crore the previous year. The quarter-on-quarter (QoQ) basis revenue dropped 3%. The average revenue per occupied bed (ARPOB) increased 15% YoY to Rs.74,800 and the bed occupancy in Q3FY24 stood at 73%.
Max Healthcare Institute Q3 Results: Net profit rises 26% YoY to Rs 338 crore
Max Healthcare Institute Chairman and Managing Director Abhay Soi said the company continued to witness positive trends on all parameters even during this quarter. This translated into revenue and profitability growth, despite expected softness in occupancies due to the festive season.
Load More
